Table 2 Medications used by our BD cohort
From: Genital ulcer severity score and genital health quality of life in Behçet’s disease
BD medication | Pt. Number/total | % |
|---|---|---|
No BD medication | 24/207 | 11.6 % |
One systemic medicine | 51/207 | 24.6 % |
Two systemic medicines | 62/207 | 30 % |
More than two systemic medicines | 42/207 | 20.3 % |
Medications’ name | ||
Prednisolone | 85/207 | 41 % |
Colchicine | 82/207 | 39.6 % |
Azathioprine | 63/207 | 30.4 % |
Mycophenolate Mofetil (MMF) | 20/207 | 9.6 % |
Infliximab | 15/207 | 7.2 % |
Humira | 12/207 | 5.7 % |
Methotrexate | 7/207 | 3.4 % |
Topical steroids oral medicine | 121/207 | 58.5 % |
Topical steroids genital medicine | 36/207 | 17.4 % |
Topical steroids skin medicine | 5/207 | 2.41 % |